KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Inventory Average (2018 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Inventory Average for 9 consecutive years, with $83.4 million as the latest value for Q1 2026.

  • For Q1 2026, Inventory Average rose 15.72% year-over-year to $83.4 million; the TTM value through Mar 2026 reached $83.4 million, up 15.72%, while the annual FY2025 figure was $80.6 million, 3.83% down from the prior year.
  • Inventory Average hit $83.4 million in Q1 2026 for Alnylam Pharmaceuticals, up from $79.1 million in the prior quarter.
  • Across five years, Inventory Average topped out at $130.4 million in Q1 2023 and bottomed at $68.6 million in Q2 2025.
  • Average Inventory Average over 5 years is $90.7 million, with a median of $83.7 million recorded in 2022.
  • Year-over-year, Inventory Average soared 58.2% in 2023 and then decreased 29.79% in 2024.
  • Alnylam Pharmaceuticals' Inventory Average stood at $122.2 million in 2022, then dropped by 24.35% to $92.5 million in 2023, then dropped by 16.45% to $77.2 million in 2024, then grew by 2.33% to $79.1 million in 2025, then increased by 5.47% to $83.4 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods came in at $83.4 million, $79.1 million, and $73.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.